Literature DB >> 19853681

Modulation of inter-vaccination interval to avoid antigenic competition in multivalent footrot (Dichelobacter nodosus) vaccines in sheep.

Om P Dhungyel1, Richard J Whittington.   

Abstract

Virulent footrot is a significant disease of sheep in most sheep farming countries; a strain/serogroup of the anaerobic bacterium Dichelobacter nodosus is the essential transmitting agent. Commercial multivalent footrot vaccines containing nine fimbrial serogroups (A through I) of D. nodosus produce relatively low and short term antibody responses due to antigenic competition, in contrast to higher and longer responses provided by monovalent or bivalent vaccines. The latter were important components of successful eradication programs for endemic footrot caused by either one or two serogroups of D. nodosus in Nepal, Bhutan, and several flocks in Australia. However, the presence of up to six serogroups in some Australian flocks and the use of an annual bivalent vaccination regime to progressively eradicate serogroups would require a long term program. In this study we report the results of a sequential vaccination trial testing different time intervals between different bivalent vaccinations. Intervals of 12, 9, 6, 3 and 0 months were tested. The 1st vaccination was with recombinant fimbrial antigens for serogroups A and B while the 2nd vaccination was with D and E. There were no significant differences between the antibody responses for time intervals of 3, 6, 9 and 12 months whereas there was a reduced response when sheep were vaccinated with two bivalent vaccines (four antigens) concurrently, indicating antigenic competition. Therefore an inter-vaccination interval of 3 months can be applied between two different bivalent vaccines without detrimental impact on the humoral immune responses to the various fimbrial antigens of D. nodosus. These results could have wider applications in vaccination against diseases caused by multivalent or multistrain microbes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19853681     DOI: 10.1016/j.vaccine.2009.10.012

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Ultrahigh resolution and full-length pilin structures with insights for filament assembly, pathogenic functions, and vaccine potential.

Authors:  Sophia Hartung; Andrew S Arvai; Timothy Wood; Subramaniapillai Kolappan; David S Shin; Lisa Craig; John A Tainer
Journal:  J Biol Chem       Date:  2011-10-24       Impact factor: 5.157

2.  The immunogenicity and tissue reactivity of Mycobacterium avium subsp paratuberculosis inactivated whole cell vaccine is dependent on the adjuvant used.

Authors:  D J Begg; O Dhungyel; A Naddi; N K Dhand; K M Plain; K de Silva; A C Purdie; R J Whittington
Journal:  Heliyon       Date:  2019-06-18

3.  Characterization of two putative Dichelobacter nodosus footrot vaccine antigens identifies the first lysozyme inhibitor in the genus.

Authors:  Maria Victoria Humbert; Alexandra Jackson; Christian M Orr; Ivo Tews; Myron Christodoulides
Journal:  Sci Rep       Date:  2019-07-11       Impact factor: 4.379

4.  Serogroups of Dichelobacter nodosus, the cause of footrot in sheep, are randomly distributed across England.

Authors:  Naomi S Prosser; Emma M Monaghan; Laura E Green; Kevin J Purdy
Journal:  Sci Rep       Date:  2020-10-08       Impact factor: 4.379

5.  Recombinant house dust mite allergens.

Authors:  Susanne Vrtala; Hans Huber; Wayne R Thomas
Journal:  Methods       Date:  2013-07-31       Impact factor: 3.608

6.  Serological Diversity of Dichelobacter nodosus in German Sheep Flocks.

Authors:  Monia Budnik; Ann-Kathrin Struck; Julia Storms; Anna Wirth; Jörg Jores; Peter Kuhnert; Ottmar Distl
Journal:  Animals (Basel)       Date:  2022-03-17       Impact factor: 2.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.